BetterLife Pharma BETRF
OTC BETRF
$0.17 +0.02 (+10.39%)
As of: Oct 21, 2026 · 12:20 PM EDT

BetterLife Pharma (BETRF) Long-Term Debt Repayments (2018 - 2026)

Updated

BetterLife Pharma (BETRF) recorded Long-Term Debt Repayments of -$2,338 in fiscal Q2 2027 (quarter ended Jul 31, 2026).

Analysis

BetterLife Pharma (BETRF) Long-Term Debt Repayments (2018 - 2026) Analysis & Trends

On a TTM basis, BetterLife Pharma's Long-Term Debt Repayments came in at -$154,066 as of Jul 31, 2026; for FY2026 (ended Jan 31, 2026), it was -$3,540.

  • Across earlier fiscal years, Long-Term Debt Repayments came in at $95,810 in FY2022.
  • The fiscal Q2 2027 figure is the highest quarterly Long-Term Debt Repayments since fiscal Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,175.59 Bn 1,144.18 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 639.41 Bn 557.93 Bn 17.26 Bn 1.00 Mn
3 AbbVie 502.56 Bn 475.67 Bn 12.70 Bn 2.00 Bn
4 Merck 375.27 Bn 329.65 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 303.16 Bn 267.15 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 268.63 Bn 242.32 Bn 12.86 Bn 2.46 Bn
7 Amgen 242.12 Bn 197.52 Bn 7.24 Bn -
8 Gilead Sciences 193.40 Bn 167.60 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.79 Bn 119.44 Bn 10.94 Bn -
10 BetterLife Pharma 24.95 Mn 24.20 Mn - -2,338.08
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 -2,338.08
Apr 30, 2026 -2,370.17
Jan 31, 2022 292,330.20
Jan 31, 2020 36,479.78
Jul 31, 2019 546,584.86
Apr 30, 2019 -563,498.07
Apr 30, 2018 12,510.41
API Access

BetterLife Pharma Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=BETRF&period=max&api_key=YOUR_API_KEY